2025 annual financial data
Senti Biosciences Holdings 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -197,472.73%.
Operating income was -63,727,000 USD and net income was -61,438,000 USD.
Operating cash flow was -43,444,000 USD.
Get free Senti Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,000 USD
- Operating income
- -63,727,000 USD
- Net income
- -61,438,000 USD
- Operating cash flow
- -43,444,000 USD